PerkinElmer's Q4 Revenues Rise 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its fourth quarter revenues increased 4 percent year over year driven by gains for its Human Health segment.

The firm reported total revenues of $593.3 million for the three months ended Dec. 29, compared to $572.9 million for the fourth quarter of 2012. It beat analysts' consensus estimate of $589.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.